Suppr超能文献

血管侵袭性脑曲霉病导致一名免疫功能正常男性出现半球梗死

Angio-invasive Cerebral Aspergillosis Resulting in Hemispheric Infarct in an Immunocompetent Man.

作者信息

Goyal Nishant, Narula Himanshu, Chaturvedi Jitender, Agrawal Sanjay, Dash Chinmaya, Meena Suneeta, Kaistha Neelam

机构信息

Department of Neurosurgery, All India Institute of Medical Sciences.

Department of Microbiology, All India Institute of Medical Sciences.

出版信息

Med Mycol J. 2020;61(3):49-53. doi: 10.3314/mmj.20-00005.

Abstract

BACKGROUND

Cerebral aspergillosis usually affects immunocompromised hosts and may rarely occur in immunocompetent individuals. Due to its angio-invasive nature, Aspergillus may cause various vascular complications, particularly mycotic aneurysms and infarcts.

CASE PRESENTATION

A 22-year-old immunocompetent male with diagnosed case of sino-cerebral aspergillosis was taking voriconazole for two months. His headache worsened and repeat imaging showed an increase in the size of the lesion. The patient was managed with right frontal craniotomy and surgical debridement, and voriconazole was continued. After ten days of uneventful post-operative course, the patient developed left-sided hemispheric infarct. The patient is doing well at nine months' follow-up, and he is off voriconazole for three months after the follow-up imaging showed complete resolution of disease.

CONCLUSION

Treatment of choice for cerebral aspergillosis is voriconazole. Surgical debridement may be a useful adjunct in patients not responding to voriconazole alone.

摘要

背景

脑曲霉病通常影响免疫功能低下的宿主,在免疫功能正常的个体中很少发生。由于其血管侵袭性,曲霉菌可能导致各种血管并发症,尤其是霉菌性动脉瘤和梗死。

病例介绍

一名22岁免疫功能正常的男性,被诊断为鼻窦-脑曲霉病,已服用伏立康唑两个月。他的头痛加重,重复影像学检查显示病变大小增加。患者接受了右额开颅手术和手术清创,并继续服用伏立康唑。术后经过十天平稳病程,患者发生左侧半球梗死。在九个月的随访中患者情况良好,在随访影像学显示疾病完全消退后,他停用伏立康唑三个月。

结论

脑曲霉病的首选治疗药物是伏立康唑。对于单独使用伏立康唑无反应的患者,手术清创可能是一种有用的辅助治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验